Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $53.9M invested in Invesco Biotechnology & Genome ETF in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.37M | |
| 2 | +$626K | |
| 3 | +$483K | |
| 4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
+$353K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$282K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$1.36M | |
| 3 | -$1.11M | |
| 4 |
YIA
YHB Investment Advisors
West Hartford,
Connecticut
|
-$1M |
| 5 |
Morgan Stanley
New York
|
-$695K |